NEW YORK & LONDON--(BUSINESS WIRE)--Apr 22, 2025--
EDITED ™, the world’s leading AI-powered retail intelligence platform, has launched its new Tariff Tracker to help retailers respond faster to the growing impact of global tariffs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422711950/en/
Powered by EDITED’s unmatched market data – tracking over 5 billion SKUs across 5,000+ retailers and 14+ years of history – the Tariff Tracker is the first tool of its kind to publicly visualize how tariffs are shaping pricing, assortment, and promotional strategies in real time.
“Retailers don’t just need to know tariffs are coming, they need to know how to react,” said Shellie Vornhagen, CMO at EDITED. “With EDITED, they get real-time insights and AI-driven recommendations to move fast, protect margins, and stay ahead of the market.”
The Tariff Tracker is just the beginning. EDITED’s full Retail Intelligence Platform gives retailers the tools to make smarter decisions in volatile conditions with:
Retailers can explore the live tracker at edited.com/tariff-tracker and learn how EDITED can help your business by registering for our webinar, 15-Minute Briefing: Smarter Tariff Strategy Starts Here.
About EDITED:
EDITED is the world’s leading AI-powered retail intelligence platform that empowers brands and retailers with real-time insights and actionable recommendations around assortment, pricing, and site merchandising. We help retailers drive better business outcomes by providing a holistic view that is market-informed, profit-aware, and customer-centric. The world’s most successful brands and retailers use EDITED’s platform to get closer to their best customers and future-proof their business.
Check out the Tariff Tracker at edited.com/tariff-tracker
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Jan 12, 2026--
ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To support its growth in the region, ChemWerth has hired Chandrakanth Reddy as general sales manager of its India office.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111302280/en/
“The addition of a general sales manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market,” said Pete Werth III, president, ChemWerth. “Chandrakanth will add tremendous value for our customers and contract manufacturing organizations (CMOs) in India.”
Reddy is a seasoned pharmaceutical professional with more than 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer partnerships and supporting sustainable revenue growth.
In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.
“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.
About ChemWerth, Inc.:
Established in 1982, ChemWerth is a full-service generic active pharmaceutical ingredient (API) development and supply company providing cGMP-quality APIs to regulated markets worldwide. ChemWerth is a global company headquartered in the United States, with offices in China and India. For more information, please visit www.chemwerth.com.
Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.
